Overview
US senior care provider's fiscal Q3 revenue rose 15.5%, beating analyst expectations
Company posted a wider net loss and higher net loss margin for the quarter
InnovAge raised full-year 2026 revenue and adjusted EBITDA guidance
Outlook
InnovAge raises fiscal 2026 revenue guidance to $950 mln-$975 mln
Company lifts full-year Adjusted EBITDA forecast to $85 mln-$90 mln
InnovAge expects census and total member months to remain unchanged for fiscal 2026
Result Drivers
CENTER PERFORMANCE - Co said stronger performance across centers drove revenue growth
HIGHER PARTICIPANT CENSUS - Increase in participant census to approximately 8,050 supported revenue growth
Company press release: ID:nGNX1xbTMx
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$251.90 mln
$234.42 mln (3 Analysts)
Q3 EPS
-$0.22
Q3 Net Loss
$29.90 mln
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"
Wall Street's median 12-month price target for InnovAge Holding Corp is $7.00, about 14.3% below its May 4 closing price of $8.17
The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 20 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)